Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms
Authors
Keywords
-
Journal
Science Advances
Volume 6, Issue 6, Pages eaav7416
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-02-08
DOI
10.1126/sciadv.aav7416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
- (2019) Gillianne G.Y. Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- Polymer thin film-induced tumor spheroids acquire cancer stem cell-like properties
- (2018) Minsuk Choi et al. CANCER RESEARCH
- Senescence-associated reprogramming promotes cancer stemness
- (2017) Maja Milanovic et al. NATURE
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
- (2017) Matthew J. Hangauer et al. NATURE
- A tool for discovering drug sensitivity and gene expression associations in cancer cells
- (2017) Yong Qin et al. PLoS One
- Toward a Better Understanding of the Complexity of Cancer Drug Resistance
- (2016) Michael M. Gottesman et al. Annual Review of Pharmacology and Toxicology
- Hallmarks of cancer stem cell metabolism
- (2016) Patricia Sancho et al. BRITISH JOURNAL OF CANCER
- mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells
- (2016) Raju V. Pusapati et al. CANCER CELL
- Exploiting Temporal Collateral Sensitivity in Tumor Clonal Evolution
- (2016) Boyang Zhao et al. CELL
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism
- (2016) Chia-Lin Chen et al. Cell Metabolism
- From Ancient Pathways to Aging Cells—Connecting Metabolism and Cellular Senescence
- (2016) Christopher D. Wiley et al. Cell Metabolism
- The cellular origins of drug resistance in cancer
- (2016) Geoffrey R Oxnard NATURE MEDICINE
- Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
- (2016) Aaron N Hata et al. NATURE MEDICINE
- Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer
- (2016) Guilhem Roubaud et al. Nature Reviews Clinical Oncology
- Combine and conquer: challenges for targeted therapy combinations in early phase trials
- (2016) Juanita S. Lopez et al. Nature Reviews Clinical Oncology
- Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
- (2016) Michael Ramirez et al. Nature Communications
- Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation
- (2016) Mark Borris D. Aldonza et al. Oncotarget
- Effects of Second and Subsequent Lines of Chemotherapy for Metastatic Breast Cancer
- (2015) In Hae Park et al. Clinical Breast Cancer
- The influence of subclonal resistance mutations on targeted cancer therapy
- (2015) Michael W. Schmitt et al. Nature Reviews Clinical Oncology
- AKT inactivation causes persistent drug tolerance to EGFR inhibitors
- (2015) Osamu Tetsu et al. PHARMACOLOGICAL RESEARCH
- Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs
- (2014) C. V. Pecot et al. MOLECULAR CANCER THERAPEUTICS
- The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors
- (2014) Francesca Pellicano et al. STEM CELLS
- Non-Darwinian dynamics in therapy-induced cancer drug resistance
- (2013) Angela Oliveira Pisco et al. Nature Communications
- Erlotinib antagonizes ABC transporters in acute myeloid leukemia
- (2012) Elodie Lainey et al. CELL CYCLE
- Drug Resistance: Challenges to Effective Therapy
- (2012) M. P.V. Shekhar CURRENT CANCER DRUG TARGETS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
- (2012) Levi A. Garraway et al. Cancer Discovery
- Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer
- (2011) E S Antonarakis et al. PROSTATE CANCER AND PROSTATIC DISEASES
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- TGF-β–FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
- (2010) Kazuhito Naka et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Tumor heterogeneity: Causes and consequences
- (2009) Andriy Marusyk et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Evolution of Resistance to Targeted Anti-Cancer Therapies during Continuous and Pulsed Administration Strategies
- (2009) Jasmine Foo et al. PLoS Computational Biology
- METgene amplification orEGFRmutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors
- (2008) Takafumi Kubo et al. INTERNATIONAL JOURNAL OF CANCER
- The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression
- (2008) R. C.-Y. Hui et al. MOLECULAR AND CELLULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started